Form 4 for ACXP Acurx Pharmaceuticals, Inc.
Accepted 2022-07-29 00:00:00 ET · period of report 2022-07-27 · accession 0001104659-22-084316 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-07-29 | 2022-07-27 | ACXP | DELUCCIA ROBERT J | Dir, 10% | P - Purchase | $3.80 | +19.7K | 1.05M | +2% | +$75.0K |
| DM | 2022-07-29 | 2022-07-27 | ACXP | DELUCCIA ROBERT J | Dir, 10% | P - Purchase | $0.00 | +39.5K | 19.7K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-27 | P | A | 19,737 | $3.80 | 1,051,198 | D | — | — | |
| 2 | Derivative | Warrants for Common Stock | 2022-07-27 | P | A | 19,737 | $0.00 | 19,737 | D | $3.55 · 2023-01-27 to 2028-01-27 | 19,737 Common Stock | |
| 3 | Derivative | Warrants for Common Stock | 2022-07-27 | P | A | 19,737 | $0.00 | 19,737 | D | $3.55 · 2023-01-27 to 2024-01-27 | 19,737 Common Stock |